FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2014/10/005085 [Registered on: 08/10/2014] Trial Registered Retrospectively
Last Modified On: 02/10/2014
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   AN EFFECT OF JATAMANSYADI VATI IN ESSENTIAL HYPERTENSION  
Scientific Title of Study   A STUDY ON VYANABALA VRIDDHI (ESSENTIAL HYPERTENSION) AND ITS MANAGEMENT WITH JATAMANSYADI VATI 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shreyas Rajeshkumar Adhvaryu 
Designation  MD scholar 
Affiliation  Institute for Post Graduate Teaching And Research in Ayurveda  
Address  Department of Kayachikitsa Institute for Post Graduate Teaching And Research in Ayurveda Gujarat Ayurved University Jamnagar Gujarat India
Shivdham Luhar Falia Bardoli Dist Surat Gujarat India
Jamnagar
GUJARAT
361008
India 
Phone  9913063278  
Fax    
Email  shreyasadhvaryu@yahoo.co.in  
 
Details of Contact Person
Scientific Query
 
Name  Dr A R Dave 
Designation  Associate Professor  
Affiliation  Institute for Post Graduate Teaching And Research in Ayurveda  
Address  Department of Kayachikitsa Institute for Post Graduate Teaching And Research in Ayurveda Gujarat Ayurved University Jamnagar Gujarat India

Jamnagar
GUJARAT
361008
India 
Phone  9824171817  
Fax    
Email  alankruta@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr A R Dave 
Designation  Associate Professor  
Affiliation  Institute for Post Graduate Teaching And Research in Ayurveda  
Address  Department of Kayachikitsa Institute for Post Graduate Teaching And Research in Ayurveda Gujarat Ayurved University Jamnagar Gujarat India


GUJARAT
361008
India 
Phone  9824171817  
Fax    
Email  alankruta@yahoo.com  
 
Source of Monetary or Material Support  
Institute for Post Graduate Teaching And Research In Ayurveda Gujarat Ayurved University Jamnagar 361008 
 
Primary Sponsor  
Name  Institute for Post Graduate Teaching And Research in Ayurveda  
Address  Institute for Post Graduate Teaching And Research in Ayurveda Gujarat Ayurved University Jamnagar Gujarat 361008 India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Shreyas Rajeshkumar Adhvaryu  OPD Department of Kayachikitsa  Institute for Post Graduate Teaching And Research in Ayurveda Gujarat Ayurved University Jamnagar 361008 India
Jamnagar
GUJARAT 
9913063278

shreyasadhvaryu@yahoo.co.in 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Institutional ethics committee IPGT and RA  Approved 
Institutional ethics committee ipgt and ra  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Vyanabala Vriddhi,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Jatamansyadi Vati  Jatamansyadi Vati 1 gm BD after meal for duration of 28 days 
Comparator Agent  Metoprolol  Metoprolol 25 or 50 mg OD for duration of 28 days 
 
Inclusion Criteria  
Age From  25.00 Year(s)
Age To  65.00 Year(s)
Gender  Both 
Details  Patients above 25 years and below 65 years of age will be selected for the study
Patients with systolic blood pressure above 140 mm of Hg and below 180 mm of Hg will be taken for the study
Patients with diastolic blood pressure above 90 mm of Hg and below 110 mm of Hg will be taken for the study
Patients presenting with the classical symptoms of Hypertension will be taken for the study
 
 
ExclusionCriteria 
Details  Patients below 25 years and above 65 years of age will be excluded from the study
Patients with systolic blood pressure below 140 mm of Hg and above 180 mm of Hg will be excluded from the study
Patients with diastolic blood pressure below 90 mm of Hg and above 110 mm of Hg will be excluded from the study
Patients having major illness like severe D.M., tuberculosis, major endocrine disorders, malignancies, HIV, renal failure will be excluded from the study
Patients having accelerated and malignant hypertension and history of cardiac compromise like angina, MI, CCF will also be excluded
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
control of hypertension  28 days 
 
Secondary Outcome  
Outcome  TimePoints 
improve quality of life  after 28 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 1/ Phase 2 
Date of First Enrollment (India)   07/04/2014 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This is a randomized control clinical trial at I P G T and R A, Gujarat Ayurved University, Jamnagar in Department of Kayachikitsa OPD. Dealing with treatment of Vyanabala Vriddhi (essential hypertension). In present study Jatamansyadi Vati which contain Jatamansi, Ashwagandha, Arjuna, Gokshura and Brahmi in equal parts will be given 1 gm BD for 28 days as interventional group. In control group Metoprolol will be given 25 mg or 50 mg OD for 28 days.
 
Close